Financials
- Market Capitalization 2.34 B
- Employee 305
- Founded 2018
- CEO David Hung
- Website www.nuvationbio.com
- Headquarter Delaware, United States
- FIGI BBG00VHJ0CC1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-14.93
Relación precio/flujo de caja
0.05
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1879 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.79 USD | -6.51% | -6.51% | -9.10% | +134.17% | 2.39 B USD | ||
| 1887 | KOD Kodiak Sciences Inc - Common Stock | 37.64 USD | -3.78% | -1.80% | -7.08% | +318.69% | 2.37 B USD | ||
| 1897 | BHVN Biohaven Ltd. Common Shares | 15.53 USD | -3.66% | +9.60% | +12.29% | -8.33% | 2.35 B USD | ||
| 1901 | PHVS Pharvaris N.V. - Ordinary Shares | 35.32 USD | -4.54% | -2.62% | +5.75% | +54.71% | 2.30 B USD |